Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CHI3L1 antibodies for the detection and/or treatment of nonalcoholic fatty liver disease/nonalcoholic steatonhepatitis and subsequent complications

Anti-CHI3L1 antibodies for the detection and/or treatment of nonalcoholic fatty liver disease/nonalcoholic steatonhepatitis and subsequent complications

US Patent 12012465 · Granted Jun 18, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CHI3L1 antibodies for the detection and/or treatment of nonalcoholic fattly2021
Anti-CHI3L1 antibodies for the detection and/or treatment of nonalcoholic fattly2021
Aspartate-β-hydroxylase induces epitope-specific T cell responses in tumors2020
Inhibitors of β-hydroxylase for treatment of cancer2020
Treating hepatitis B virus infections by administering receptor associated prote2019
Inhibitors of beta-hydroxylase for treatment of cancer2017
Treatment, prevention, and reversal of alcohol-induced liver disease2017
Dendritic cell vaccines for asparaginyl-β-hydroxylase expressing tumors2017
Methods, compositions and kits for imaging cells and tissues using nanoparticles2016
Treatment, prevention, and reversal of alcohol-induced brain disease2016
Use of biomarkers in methods for the treatment of hepatocellular carcinoma2014
Wnt proteins and detection and treatment of cancer2012